Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2022-08-01
2026-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TN cohort
The patient was diagnosed with trigeminal neuralgia which has active symptoms in the past 30 days.
Clinical appointment
One clinical interview and examination to confirm the diagnosis of trigeminal neuralgia and temporomandibular disorder.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical appointment
One clinical interview and examination to confirm the diagnosis of trigeminal neuralgia and temporomandibular disorder.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with trigeminal neuralgia
* Has active pain symptoms in the past 30 days
Exclusion Criteria
* Patients with psychiatric disorders that might alter pain perception
* Adults lack the capacity to provide informed consent.
* Persons under the age of 18.
* All vulnerable populations.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins University
OTHER
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Donald Nixdorf, DDS,MS
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Qiman Gao, DDS,MS,PhD
Role: STUDY_DIRECTOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John Hopkins University
Baltimore, Maryland, United States
University of Minnesota, Department of Neurosurgery
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JHU IRB No. 00388974
Identifier Type: OTHER
Identifier Source: secondary_id
UMN IRB No. 00008873
Identifier Type: -
Identifier Source: org_study_id